Skip to content

Efficacy and Tolerance Evaluation of a Revitalizing Face Treatment

Efficacy and Tolerance Evaluation of a Revitalizing Face Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03276897
Enrollment
22
Registered
2017-09-08
Start date
2017-03-21
Completion date
2017-06-30
Last updated
2017-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Face Aging/Photo Aging of Moderate Grade

Brief summary

Efficacy and Tolerance Evaluation of arevitalizing face treatment consisting of a day and a night cream

Detailed description

Aim of the study was to evaluate clinically and by non-invasive instrumental evaluations the activity of a revitalizing face treatment consisting of a day and a night cream, applied for an uninterrupted period of 3 months, by female volunteers, aged 35-60 years, with aging/photo aging of moderate grade.

Interventions

OTHERNutriage SPF 30 day cream and Nutriage night cream (Difa Cooper S.p.a, Italy)

A fixed quantity of both cosmetic products was applied for an uninterrupted period of 3 months, on the face included the submental area (day cream at the morning and the night cream at the evening), preferentially always at the same hour, with a mild massage

Sponsors

Derming SRL
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* female sex, * age 35-60 years, * Caucasian subjects, * presence of moderate face ritidosis, * agreeing to present at each study visit without make-up, * accepting to follow the instructions received by the investigator, * accepting to not change their habits regarding food, physical activity, face cleansing and make- up use, * agreeing not to apply or take any product or use face massages or other means known to improve skin wrinkle and skin qualities during the entire duration of the study, * accepting not to expose their face to strong UV irradiation (UV session, or sun bathes), during the entire duration of the study, * no participation in a similar study currently or during the previous 3 months * accepting to sign the Informed consent form.

Exclusion criteria

* Pregnancy, * lactation, * sensitivity to the test products or their ingredients (to be assessed by the investigator during the baseline visit), * subjects whose insufficient adhesion to the study protocol is foreseeable. * presence of cutaneous disease on the tested area as lesions, scars, malformations, * recurrent facial/labial herpes, * clinical and significant skin condition on the test area (e.g. active eczema, dermatitis, psoriasis etc.). * endocrine disease, * hepatic disorder, * renal disorder, * cardiac disorder, * pulmonary disease, * cancer, * neurological or psychological disease, * inflammatory/immunosuppressive disease, * drug allergy. * anti-inflammatory drugs, anti-histaminic, topic (application on the face) and systemic corticosteroids, narcotic, antidepressant, immunosuppressive drugs (with the except of hormonal treatment starting more than 1 year ago), * using of drugs or dietary supplements able to influence the test results in the investigator opinion.

Design outcomes

Primary

MeasureTime frameDescription
Change of vascular and pigmentary homogeneity clinical scoreBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)Homogeneity grade was determined according to specific reference clinical and photographic scales and to the following clinical score: 0 = very homogeneous 1. = homogeneous 2. = quite not homogeneous 3. = not homogeneous 4. = very not homogeneous 5. = marked not homogeneous
Change of skin recovery after pinching clinical scoreBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)The evaluation was performed at level of cheek (malar region) according to the following score: 0 = very important 1. = important 2. = moderate 3. = weak 4. = very weak
Change of skin dryness clinical scoreBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)Clinical evaluation of skin dryness was performed according to the following score: 0 = very hydrated skin 1. = hydrated skin 2. = normal skin 3. = kindly dry skin 4. = dry skin 5. = very dry skin
Change of skin resistance to pinching clinical scoreBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)The evaluation was performed at level of cheek (malar region) according to the following score: 0 = very important 1. = important 2. = moderate 3. = weak 4. = very weak
Change of wrinkles grade, around the eyes (Crow's feet)Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)Variation of wrinkles grade from baseline of the Glogau's reference photographic scale (visual score from 1-4) where: * Type 1: early wrinkles * Type 2: wrinkle in motion * Type 3: wrinkles at rest * Type 4: Only wrinkles
Change of wrinkles grade of nasolabial foldsBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)Variation of wrinkles grade from baseline of the Lemperle's reference photographic scale (visual score from 1-6) where: * Grade 1: no wrinkles * Grade 2: just perceptible wrinkles * Grade 3: shallow wrinkles * Grade 4: moderately deep wrinkles * Grade 5: deep wrinkles, well-defined folds * Grade 6: very deep wrinkles, redundant fold
Change of skin surface microrelief's regularityBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)Variation of skin surface microrelief's regularity grade from baseline of cheek surface microrelief photographic scale where: * Grade 1:very regular * Grade 2: regular * Grade 3: irregular * Grade 4: very irregular.
Change of skin resistance to traction clinical scoreBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)The evaluation was performed at level of cheek (malar region) according to the following score: 0 = very important 1. = important 2. = moderate 3. = weak 4. = very weak

Secondary

MeasureTime frameDescription
Photographic documentation (3D pictures)Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)Three-dimensional pictures of the face taken by VECTRA H1 handheld imaging system.
Change of roughness profilometric parametersBaseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)Crow's feet profilometric parameters measured by Primos compact portable device (GFMesstechnik). Ra is average roughness of the analysed profile, Rt is wrinkles total high, Rv is wrinkles maximum depth.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026